Our experienced pathologists help guide treatment decisions by providing diagnoses, and by testing and evaluating cancer risks and prognoses. We offer diagnostic testing for oncologic drug therapy to guide treatment and decrease treatment costs and have a large menu of established tumor markers available, including traditional markers such as CEA, CA-GI, and CA 27 and 29.
We also offer comprehensive consultation services and employ best-in-class technology, including molecular pathology testing such as FISH, DNA sequencing, and PCR. In addition, we have an extensive immunohistochemistry menu to test protein expression.
Tests
- ALK/RET/ROS1 Lung Cancer Fusion (NGS), FFPE
- Alpha-Fetoprotein, Serum
- Breast Carcinoma-Associated Antigen (CA 27.29), Serum
- Cancer Antigen 125
- Cancer Antigen 15-3
- Carbohydrate Antigen 19-9 (CA 19-9)
- Carcinoembryonic Antigen (CEA)
- CEBPA Mutation Analysis, PB or BM
- Chromosome Analysis, Cancer, Peripheral Blood
- Erythropoietin Level
- Methotrexate Level
- Prolactin
- Prostate Specific Antigen, (Non-Screening)
- Prostate Specific Antigen, Screening
- Prostate Specific Antigen, Total and Free